BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15316904)

  • 1. Time interval to the development of breast carcinoma after treatment for Hodgkin disease.
    Wendland MM; Tsodikov A; Glenn MJ; Gaffney DK
    Cancer; 2004 Sep; 101(6):1275-82. PubMed ID: 15316904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB; Neugut AI
    Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer after mantle field irradiation for Hodgkin's disease].
    Katz A; Brenner B; Sulkes A; Luria H; Marshak G; Fenig E
    Harefuah; 2000 May; 138(10):823-5, 911. PubMed ID: 10883245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?
    Chen J; Lee RJ; Tsodikov A; Smith L; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1474-9. PubMed ID: 15050326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in women following mantle irradiation for Hodgkin's disease.
    Peters MH; Sonpal IM; Batra MK
    Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second neoplasms after megavoltage radiation for pediatric tumors.
    Gold DG; Neglia JP; Dusenbery KE
    Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of multiple primary breast and thyroid carcinomas.
    Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
    Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
    Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ
    Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
    El-Gamal H; Bennett RG
    J Am Acad Dermatol; 2006 Dec; 55(6):981-9. PubMed ID: 17097395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.
    Mery CM; George S; Bertagnolli MM; Raut CP
    Cancer; 2009 Sep; 115(18):4055-63. PubMed ID: 19526590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
    Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
    Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Teta MJ; Lau E; Sceurman BK; Wagner ME
    Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma].
    Fosså SD; Holte H; Holmen MM; Bjøro T; Langmark F; Hess SL; Kvaløy S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):41-4. PubMed ID: 15643464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant breast tumors after radiotherapy for a first cancer during childhood.
    Guibout C; Adjadj E; Rubino C; Shamsaldin A; Grimaud E; Hawkins M; Mathieu MC; Oberlin O; Zucker JM; Panis X; Lagrange JL; Daly-Schveitzer N; Chavaudra J; de Vathaire F
    J Clin Oncol; 2005 Jan; 23(1):197-204. PubMed ID: 15625374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk following irradiation for Hodgkin's disease.
    Clemons M; Loijens L; Goss P
    Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculated risk of breast cancer following mantle irradiation determined by measured dose.
    Janjan NA; Zellmer DL
    Cancer Detect Prev; 1992; 16(5-6):273-82. PubMed ID: 1473117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.